Copyright ©The Author(s) 2015.
World J Hepatol. Feb 27, 2015; 7(2): 165-176
Published online Feb 27, 2015. doi: 10.4254/wjh.v7.i2.165
Figure 2
Figure 2 Schematic overview of (simplified) signaling pathways involved in the tumor-stroma interaction, and therapeutic targets that are currently tested in hepatocellular carcinoma. IL: Interleukin; TGF: Transforming growth factor; mTOR: Mammalian target of rapamycin.